Work

Tibial Lead Levels and Erythropoiesis Stimulating Agent Dosing among 75 Patients with End-Stage Kidney Disease

Year: 2024

Type: article

Source: Environmental Health Perspectives

DOI: 10.1289/ehp14199

Authors: Voravech Nissaisorakarn, Aaron Specht, John Danziger

Institutions: Beth Israel Deaconess Medical Center, Harvard University, Purdue University West Lafayette

Language: English

Topic: Erythropoietin and Anemia Treatment

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $4,500

OpenAlex ID: W4396231761

FWCI:

Cites: 10

Cited by:

Related to: 10